We are facing a global crisis where bacterial infections are becoming increasingly deadly due to antibiotic resistance. The health and economic consequences are staggering, with bacterial disease predicted to be the #1 cause of death by 2050. Alternatives are urgently needed, but nature already has its solution: phages, the natural predators of bacteria. At Phagos, we are bringing back phage technology by combining advances in microbiology with cutting-edge artificial intelligence. Our patented technology makes large-scale, customized phage-based veterinary medicines possible for the first time. And soon we'll universalize the technology for human health too. Our mission is to end bacterial disease.
| Website | https://phagos.com |
| Employees | 74 (34 on RocketReach) |
| Founded | 2021 |
| Address | Rue Gardenat Lapostol, Suresnes, Île-de-France 92150, FR |
| Industry | Biotechnology Research |
| Keywords | Antimicrobial Resistance, Infectious Disease Research, Pharmaceutical Research, Innovative Therapeutics, Infection Control, Disease Prevention, Drug Discovery, Health Technology, Pharmaceutical Development, Clinical Trials, Global Health Initiatives, Public Health Solutions, Life Sciences, Medical Research, Healthcare Solutions |
Looking for a particular phagos employee's phone or email?
Adèle James is the Co-founder and CTO of phagos.
34 people are employed at phagos.
phagos is based in Suresnes, Île-de-France.